Star Pharma

Star Pharma: Issued a profit warning; the Group is expected to report a loss for 4Q FY2012 and the financial year ended 31 December 2012. Noting that the Group’s financial results were adversely affected by a substantial write-off of an intangible asset of Category I Chinese Medicine Drug, Yanning Capsules, and allowance for impairment of deposit due to termination contract of R&D patent right acquisition.